Osaic Holdings
ORIC icon

Osaic Holdings’s Oric Pharmaceuticals ORIC Stock Holding History

Osaic Holdings’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.62K Buy
759
+76
+11% +$863 ﹤0.01% 6317
2025
Q4 		$5.59K Buy
683
+664
+3,495% +$7.64K ﹤0.01% 6649
2025
Q3 		$228 Sell
19
-1
-5% -$11 ﹤0.01% 7681
2025
Q2 		$203 Buy
+20
New +$134 ﹤0.01% 7500
2024
Q2 		– Sell
-281
Closed -$3.86K – 7559
2024
Q1 		$3.86K Buy
281
+31
+12% +$368 ﹤0.01% 6208
2023
Q4 		$2.3K Sell
250
-250
-50% -$1.81K ﹤0.01% 6493
2023
Q3 		$3.02K Buy
+500
New +$4.1K ﹤0.01% 6463
2022
Q2 		– Sell
-264
Closed -$1K – 7526
2022
Q1 		$1K Buy
+264
New +$2.38K ﹤0.01% 7091

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Osaic Holdings's ORIC Position: Q1 2026 in Review

Osaic Holdings increased its Oric Pharmaceuticals (ORIC) stake by 11% in Q1 2026, buying an estimated $863 and bringing the position to 759 shares worth $9.62K. The position accounts for ﹤0.01% of the portfolio, ranked #6317.

Osaic Holdings first reported a position in ORIC in Q1 2022 and has held it in 8 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Osaic Holdings held 759 shares of Oric Pharmaceuticals worth $9.62K as of Q1 2026.
  • Osaic Holdings bought 76 Oric Pharmaceuticals shares in Q1 2026, an estimated $863.
  • Oric Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6317 holding.
  • Osaic Holdings first reported a position in Oric Pharmaceuticals in Q1 2022 and has held it in 8 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.